Divi's Laboratories Limited (NSE:DIVISLAB)
India · Delayed Price · Currency is INR 10,038
-27 (-0.26%)
Nov 4, 2026, 3:29 PM IST
Divi's Laboratories Stock Forecast
Stock Price Forecast
According to 28 analysts polled by S&P Global, Divi's Laboratories stock has a consensus rating of "Hold" and an average price target of ₹8,693. The average 1-year stock price forecast is 13.39% lower than the current stock price, while the lowest is ₹6,500 (-35.24%) and the highest is ₹11,700 (+16.56%).
Price Target: ₹8,693 (-13.39%)
Analyst Consensus: Hold
Price Target
Chart* Price targets were last updated on Aug 4, 2026.
Analyst Ratings
The average analyst rating for Divi's Laboratories stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 | Nov '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 10 | 10 | 10 | 10 | 9 | 9 |
| Buy | 5 | 5 | 4 | 4 | 5 | 5 |
| Hold | 6 | 6 | 6 | 6 | 6 | 5 |
| Sell | 6 | 6 | 6 | 6 | 6 | 6 |
| Strong Sell | 3 | 3 | 3 | 3 | 3 | 3 |
| Total | 30 | 30 | 29 | 29 | 29 | 28 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| J.P. Morgan | J.P. Morgan | Buy Maintains ₹9,100 | Buy | Maintains | ₹9,100 | -9.34% | Aug 4, 2026 |
| Goldman Sachs | Goldman Sachs | Buy Upgrades ₹8,035 | Buy | Upgrades | ₹8,035 | -19.95% | May 29, 2026 |
Financial Forecast
Revenue This Year
126.25B
from 105.60B
Increased by 19.56%
Revenue Next Year
150.61B
from 126.25B
Increased by 19.29%
EPS This Year
125.03
from 98.86
Increased by 26.47%
EPS Next Year
151.71
from 125.03
Increased by 21.34%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is INR.